M. Kavarana

发表

Design, synthesis and selection of DNA-encoded small-molecule libraries.

Baoguang Zhao, Cecil E. Rise, M. Gefter, 2009, Nature chemical biology.

Erratum: Design, synthesis and selection of DNA-encoded small-molecule libraries

Baoguang Zhao, Cecil E. Rise, M. Gefter, 2009 .

De novo assembly and annotation of transcriptomes from two cultivars of Cannabis sativa with different cannabinoid profiles.

Joshua Orvis, P. McGarvey, M. Kavarana, 2020, Gene.

A new method for rapidly generating inhibitors of glyoxalase I inside tumor cells using S-(N-aryl-N-hydroxycarbamoyl)ethylsulfoxides.

M. Kavarana, J. Eiseman, D. J. Creighton, 1999, Journal of medicinal chemistry.

Exploring the Stereostructural Requirements of Peptide Ligands for the Melanocortin Receptors

P. Grieco, V. Hruby, M. Cai, 2003, Annals of the New York Academy of Sciences.

Synthesis and evaluation of alkoxy-phenylamides and alkoxy-phenylimidazoles as potent sphingosine-1-phosphate receptor subtype-1 agonists.

A. Saha, G. Hannig, M. Kavarana, 2009, Bioorganic & medicinal chemistry letters.

Role of hydrophobic interactions in binding S-(N-aryl/alkyl-N-hydroxycarbamoyl)glutathiones to the active site of the antitumor target enzyme glyoxalase I.

M. Kavarana, D. J. Creighton, D. Whalen, 2000, Journal of medicinal chemistry.

Novel cyclic templates of alpha-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptors.

Paolo Grieco, Jinfa Ying, Jinfa Ying, 2002, Journal of medicinal chemistry.

Exploration of amino alcohol derivatives as novel, potent, and highly selective sphingosine-1-phosphate receptor subtype-1 agonists.

A. Saha, G. Hannig, A. Satz, 2010, Bioorganic & medicinal chemistry letters.

Synthesis and evaluation of arylalkoxy- and biarylalkoxy-phenylamide and phenylimidazoles as potent and selective sphingosine-1-phosphate receptor subtype-1 agonists.

A. Saha, G. Hannig, A. Satz, 2009, Bioorganic & medicinal chemistry letters.

Pharmacokinetics and antitumor properties in tumor-bearing mice of an enediol analogue inhibitor of glyoxalase I

M. Kavarana, J. Eiseman, D. Sentz, 2000, Cancer Chemotherapy and Pharmacology.

Reaction mechanism of glyoxalase I explored by an X-ray crystallographic analysis of the human enzyme in complex with a transition state analogue.

A D Cameron, B. Mannervik, A. Cameron, 1999, Biochemistry.

Solution structures of cyclic melanocortin agonists and antagonists by NMR.

Jinfa Ying, V. Hruby, K. Kövér, 2003, Biopolymers.

Mechanism-based competitive inhibitors of glyoxalase I: intracellular delivery, in vitro antitumor activities, and stabilities in human serum and mouse serum.

E G Kovaleva, E. Kovaleva, M. Kavarana, 1999, Journal of medicinal chemistry.

S-(N-aryl-N-hydroxycarbamoyl)glutathione derivatives are tight-binding inhibitors of glyoxalase I and slow substrates for glyoxalase II.

M. Kavarana, D. J. Creighton, D. Hamilton, 1994, Journal of medicinal chemistry.

The Development of a Novel Highly Selective and Potent Agonist for Human Melanocortin 4 Receptor

V. Hruby, M. Kavarana, D. Trivedi, 2001 .